Corporate borrowers shrugged off fears over inflation and concerns over tariffs to print tight trades and pay for ...
Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a ...
Despite policy developments from the Trump administration and shifts in the AI sector, equity markets remained resilient, so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results